International Journal of Innovative Technologies in Social Science
Latest advances in the treatment of acute lymphoblastic leukemia: A narrative review of novel targeted and immunotherapeutic strategies
By Karolina Skórka, Oliwia Żmuda, Natalia Skórka and 7 others.
Abstract
Objectives
Acute lymphoblastic leukemia (ALL) treatment is changing rapidly as immunotherapy, targeted drugs, and measurable residual disease (MRD) testing move into routine care. This review summarizes major therapeutic advances reported between 2019 and 2026.